Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Royal Bank of Canada
(TSX:
RY
)
235.84
+1.99 (+0.85%)
Streaming Delayed Price
Updated: 3:04 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Royal Bank of Canada
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
31
32
Next >
RBC Capital Maintains Sector Perform Rating for GMS: Here's What You Need To Know
↗
March 01, 2024
Via
Benzinga
RBC Capital Maintains Outperform Rating for Gaming and Leisure Props: Here's What You Need To Know
↗
February 29, 2024
Via
Benzinga
Shift4 Payments: Analysts Highlight Growth Opportunities Despite Q4 Challenges
↗
February 28, 2024
RBC Capital analyst maintained Shift4 Payments with Outperform rating and raised price target from $80 to $94. Q1 revenue projected at $279.6M.
Via
Benzinga
Warrior Met Coal's Ballooning Development Costs Prompt Analysts To Rethink Projections
↗
February 23, 2024
RBC analysts lower price target for Warrior Met Coal to $64 due to higher costs at Blue Creek mine. Capex expected to be $1B in 2024.
Via
Benzinga
What's Going On With Booking Holdings Stock After Earnings?
↗
February 23, 2024
RBC Capital analyst Brad Erickson maintained Booking Holdings with an Outperform and raised the price target from $3550 to $3900, and Wedbush analyst Scott Devitt reiterated Booking Holdings with an...
Via
Benzinga
Preview: RBC Bearings's Earnings
↗
February 07, 2024
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
↗
February 23, 2024
Via
Benzinga
Navigating Discover's Merger With Capital One: Analyst Highlights Opportunities And Challenges Ahead
↗
February 22, 2024
RBC Capital Markets downgrades Discover Financial to Sector Perform with increased price target of $140. Merger with Capital One expected to be accretive and generate $2.7B in synergies. Analyst sees...
Via
Benzinga
Here's How Much You Would Have Made Owning RBC Bearings Stock In The Last 15 Years
↗
February 21, 2024
Via
Benzinga
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
↗
February 16, 2024
Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset...
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for NMI Holdings: Here's What You Need To Know
↗
February 15, 2024
Via
Benzinga
RBC Illuminates Solar Sector, Launches Coverage For 4 Solar Equipment Leaders
↗
February 14, 2024
RBC Capital Markets highlighted favorable public policy and declining costs within the solar industry and initiated coverage on several solar equipment suppliers, including First Solar, Enphase Energy,...
Via
Benzinga
Topics
Supply Chain
RBC Capital Maintains Outperform Rating for Datadog: Here's What You Need To Know
↗
February 14, 2024
Via
Benzinga
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
↗
February 09, 2024
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...
Via
Benzinga
RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
↗
February 09, 2024
IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Outperform, anticipating $21 price target. Data expected in 2H 2024 validates its...
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Thomson Reuters: Here's What You Need To Know
↗
February 09, 2024
Via
Benzinga
RBC Capital Maintains Outperform Rating for Ensign Group: Here's What You Need To Know
↗
February 06, 2024
Via
Benzinga
Uber, Lyft Can Hitch A Ride Higher If Q4 Earnings Beat Wall Street Estimates
↗
February 05, 2024
Uber reports on Wednesday, while Lyft Q4s are on Feb. 13. RBC has a sector perform rating on Lyft and an outperform rating on Uber.
Via
Benzinga
Topics
Earnings
Capstone Copper Announces Multimillion-Dollar Financing To Support Its Chilean Expansion
↗
February 05, 2024
Capstone Copper Corp. and Orion Mine Finance arranged a CA$375 million bought deal with RBC Capital Markets, expected to close on Feb. 8, 2024.
Via
Benzinga
RBC Capital Maintains Outperform Rating for Reinsurance Gr: Here's What You Need To Know
↗
February 05, 2024
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
↗
February 02, 2024
Via
Benzinga
RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know
↗
February 01, 2024
Via
Benzinga
What's In Store For Clorox This Earnings Season? Analyst Sees Issues With Trash Bags, Cat Litter & More
↗
January 30, 2024
Clorox faces challenges in key product categories like trash bags and cat litter, hindering recovery from the 2023 cyber-attack, according to RBC analyst Nik Modi.
Via
Benzinga
'We Stay The Course On Meta And Amazon': Analysts Preview Tech Earnings
↗
January 29, 2024
RBC is looking for acceleration in Amazon's AWS cloud offering and expects increasing adoption of Advantage+ to be a key driver of Meta.
Via
Benzinga
Foresight to Participate in A.G.P’s Virtual Technology Conference
January 29, 2024
--News Direct--
Via
News Direct
Topics
Regulatory Compliance
Foresight to Participate in A.G.P’s Virtual Technology Conference
January 29, 2024
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“FRSX” or the “Company”), an innovator in automotive vision systems, today announced that management will participate in the Alliance Global...
Via
TheNewswire.com
Topics
Regulatory Compliance
RBC Capital Maintains Outperform Rating for Popular: Here's What You Need To Know
↗
January 26, 2024
Via
Benzinga
Axsome Depression Drug's Commercial Success, Pipeline Potential Undervalued, Analyst Says
↗
January 25, 2024
Axsome Therapeutics' growth potential with RBC Capital's optimistic coverage. Auvelity's rapid Rx growth projects sales of $296M in 2024, outperforming estimates.
Via
Benzinga
RBC Capital Maintains Outperform Rating for ServiceNow: Here's What You Need To Know
↗
January 25, 2024
Via
Benzinga
Post Event Report - The Future of Insurance Canada 2023
January 25, 2024
London, United Kingdom--(Newsfile Corp. - January 25, 2024) - In 2023 business was anything but as usual. Spiraling costs, accelerated...
Via
Newsfile
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
